The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8

COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
BIOVENTUS INC COM CL A 09075A108   87,112,658 13,021,324 SH   SOLE   13,021,324 0 0
EYEPOINT PHARMACEUTICALS INC COM NEW 30233G209   15,448,362 1,084,857 SH   SOLE   1,084,857 0 0
MEDICINOVA INC COM NEW 58468P206   1,404,545 1,105,941 SH   SOLE   1,105,941 0 0
MIMEDX GROUP INC COM 602496101   196,802,838 28,195,249 SH   SOLE   28,195,249 0 0
TELA BIO INC COM 872381108   6,124,956 4,110,709 SH   SOLE   4,110,709 0 0
VENUS CONCEPT INC COM 92332W303   227,748 99,021 SH   SOLE   99,021 0 0